{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:14:21Z","timestamp":1774127661485,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.therap.2017.10.005","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T20:01:07Z","timestamp":1510862467000},"page":"193-198","source":"Crossref","is-referenced-by-count":8,"title":["Pigmentation cutan\u00e9e li\u00e9e \u00e0 l\u2019extravasation de fer injectable. Analyse de la base fran\u00e7aise de pharmacovigilance de 2000\u00a0\u00e0 2016"],"prefix":"10.1016","volume":"73","author":[{"given":"Alexia","family":"Hermitte-Gandoliere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Petitpain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Lepelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Le Beller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline Ponte","family":"Astoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Gillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2017.10.005_bib0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.blre.2017.02.004","article-title":"New insights into iron deficiency and iron deficiency anemia","volume":"31","author":"Camaschella","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.therap.2017.10.005_bib0055","series-title":"Agence nationale du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Sp\u00e9cialit\u00e9s \u00e0 base de fer pour injection intraveineuse\u00a0: une utilisation r\u00e9serv\u00e9e aux \u00e9tablissements de sant\u00e9 en raison du risque de r\u00e9actions graves d\u2019hypersensibilit\u00e9. Point d\u2019information","year":"2013"},{"key":"10.1016\/j.therap.2017.10.005_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.therap.2016.02.010","article-title":"Causality assessment in pharmacovigilance: the French method and its successive updates","volume":"71","author":"Miremont-Salam\u00e9","year":"2016","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2017.10.005_bib0065","series-title":"Point sur le risque de r\u00e9actions allergiques graves avec le fer dextran (Ferrisat) compar\u00e9 au complexe hydroxyde ferrique-saccharose (Venofer)","author":"Commission nationale de pharmacovigilance.","year":"2010"},{"key":"10.1016\/j.therap.2017.10.005_bib0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/imj.12467","article-title":"Severe haemosiderin pigmentation after intravenous iron infusion","volume":"44","author":"Thompson","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.therap.2017.10.005_bib0075","series-title":"Minist\u00e8re des affaires sociales et de la sant\u00e9, Direction g\u00e9n\u00e9rale de l'offre de soins. Instruction DGOS\/PF2\/R3\/DGS\/PP2\u00a0no\u00a02014\u201332\u00a0du 24\u00a0janvier\u00a02014\u00a0relative aux modalit\u00e9s d\u2019utilisation des sp\u00e9cialit\u00e9s \u00e0 base de fer injectable","year":"2014"},{"key":"10.1016\/j.therap.2017.10.005_bib0080","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/lsm.1074","article-title":"Circumscripted pigmentations after iron injections-treatment with Q-switched laser systems","volume":"28","author":"Raulin","year":"2001","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.therap.2017.10.005_bib0085","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/DSS.0000000000000513","article-title":"Hemosiderin hyperpigmentation: successful treatment with Q-switched 755-nm laser therapy","volume":"41","author":"Gan","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.therap.2017.10.005_bib0045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/jdv.12417","article-title":"Successful treatment with 532-nm Q-switched Nd:YAG laser of cutaneous siderosis following intravenous iron extravasation","volume":"29","author":"Hammami Ghorbel","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595717301841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595717301841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T08:18:41Z","timestamp":1554279521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595717301841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0040595717301841"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2017.10.005","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}